Detalhe da pesquisa
1.
Effectiveness of Oral Nirmatrelvir/Ritonavir vs. Intravenous Three-Day Remdesivir in Preventing Progression to Severe COVID-19: A Single-Center, Prospective, Comparative, Real-Life Study.
Viruses
; 15(7)2023 07 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37515201